The hypothesis of this study is that reductions in body weight could improve inspiratory muscle function attenuating the inspiratory metaboreflex in metabolically healthy obese individuals and obese individuals with metabolic syndrome.
Introduction: Peripheral metaboreflex activation appears to be exacerbated in obese individuals with metabolic syndrome. Interestingly, bariatric surgery attenuates the peripheral metaboreflex. Obese individuals have impaired inspiratory muscle function, which can be reversed by the reduction in body weight. Therefore, bariatric surgery could attenuate inspiratory metaboreflex in metabolically healthy obese individuals and obese individuals with metabolic syndrome. Objectives: To investigate the effects of bariatric surgery on inspiratory metaboreflex in metabolically healthy obese individuals and in obese patients with metabolic syndrome. Patients and Methods: A sample comprising of 15 obese subjects with metabolic syndrome, 15 obese subjects without metabolic syndrome and 15 healthy nonobese individuals. These subjects will be submitted to pulmonary function, respiratory muscle strength, inspiratory muscle resistance, exercise tolerance, quality of life, autonomic cardiovascular control and the inspiratory metaboreflex evaluation. The evaluations performed in obese patients with and without metabolic syndrome pre-surgery will be repeated 6 months after bariatric surgery.
Study Type
OBSERVATIONAL
Enrollment
45
evaluations pre and post bariatric surgery.
without intervention, it will be performed only evaluations
University of Cruz Alta
Cruz Alta, Rio Grande do Sul, Brazil
RECRUITINGInspiratory metaboreflex
It will be induced through a linear inspiratory resistance of 60% of maximal inspiratory pressure
Time frame: 6 monhs
Pulmonary function
It will be assessed by spirometry
Time frame: 6 months
Respiratory muscle strength
It will be determined by manovacuometry.
Time frame: 6 months
Inspiratory muscle resistance
It will be evaluated through a protocol with progressive increase in inspiratory resistance.
Time frame: 6 months
Autonomic cardiovascular control
It will be determined by spectral analysis
Time frame: 6 months
Exercise tolerance
It will be determined by the 6-minute walk test.
Time frame: 6 months
Quality of life
It will be determined through the SF36 questionnaire.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.